Research Paper Volume 13, Issue 5 pp 7499—7516

BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma

class="figure-viewer-img"

Figure 2. Gene Ontology analysis for BDKRB2 in pan-glioma (A, B) and glioblastoma (C, D).